Danone has capitalized on a surge in U.S. consumer demand for high-protein foods, reporting double-digit volume growth in its Oikos Greek yogurt line over the past year. According to CoBank’s Knowledge Exchange report, 70% of American consumers now seek to increase dietary protein, up from 59% in 2022. Ready-to-drink protein shakes—an adjacent category in which Danone supplies branded and private-label dairy ingredients—grew 71% in dollar sales over the last four years, from $4.7 billion to $8.1 billion. Adoption of GLP-1 weight-loss medications by 12% of U.S. adults in late 2025 further accelerated demand, with formulators turning to Danone’s whey and milk proteins to boost nutrition in bars, beverages and baked goods. High-protein claims carry price premiums of up to 12%, enhancing Danone’s margin potential in both retail dairy and ingredient sales channels.

On January 23, 2026, Danone announced a targeted recall of a limited number of infant formula batches produced in Ireland, in response to updated guidance from local food-safety authorities. The company emphasized that routine and additional analyses confirm its products remain fully compliant with safety regulations. The recall affects specific markets where guidance has evolved, and Danone has activated its customer care line to address inquiries from parents and healthcare professionals. While the action is narrowly scoped, investors will monitor any potential impact on Danone’s Specialized Nutrition division, which accounted for approximately 15% of the company’s €27.4 billion in 2024 sales and includes leading brands such as Aptamil and Nutrilon.